|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Find a Clinical Trial
Eczema/Dermatitis
Also called atopic eczema, this is a chronic, hereditary, condition often triggered by environmental factors. The skin itches intensely and is dry and inflamed, with episodes of redness, weeping, crusting, cracking, and scaling. Atopic dermatitis most often affects infants and young children, but it can continue into adulthood or even first occur later in life. The condition fluctuates, with exacerbations or flares. The disease is associated with other so-called atopic disorders, such as hay fever and asthma.
Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial. For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy. Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.
Pediatric Eczema Elective Registry (PEER Program)
Novartis Pharmaceuticals Corporation is sponsoring a Pediatric Eczema Elective Registry (PEER) to monitor the long-term safety of topical calcineurin inhibitors. This scientific observational registry is designed to collect information from the parents of approximately 5000 children across the USA between the ages of 2 years and 17 years (at enrollment) who have used and may continue to use Elidel® for the treatment of eczema. For more information on this program, please visit www.childrenseczemaregistry.com or call1-877-711-7337
Trial phase: Phase 4 Participation Duration: Up to 10 years from the time of enrollment. Protocol Number: CASM981CUS2311 |